OCTLIGHT has for the second time been selected as one of the beneficiaries of the Horizon 2020 EU SME Instrument. Read the official press release here.

With the project “Innovative Swept Source for next generation OCT devices” OCTLIGHT will participate in Phase 1 of the instrument, granting the company €50,000 to be used for exploring and assessing the commercial potential of our technology.

This time around, the project will focus on developing a business plan for our second OCT product line, Ozzy, which utilizes our MEMS-VCSEL technology. The technology is currently being developed in our Eurostars funded project focusing on demonstrating MHz SS-OCT for wide-field Ophthalmic imaging.

The outcome will be a more solid understanding of the technology’s market potential as well as integration with the current market. This will benefit end-customers with an unmatched value proposition for a step change in performance of Ophthalmic imaging.

We are very excited to undergo this project. Be sure to subscribe to our newsletter for more information on our development progress.

Biophotonics is multifaceted and has significant potential for innovation. The industry will come together from June 24 to 27, 2019 in Munich for LASER World of PHOTONICS, the world’s leading trade fair with congress for photonics components, systems and applications. Half a year before the fair, more than 130 international exhibitors from all areas of biophotonics have already announced their attendance. Studies predict that the sector will achieve global sales of 85.5 billion Euros by 2020—with annual growth of seven percent.

LASER World of PHOTONICS, the world’s leading Trade Fair with Congress for Photonics Components, Systems and Applications, has more than 32,700 visitors from 73 countries and 1,290 exhibitors from 42 countries.

OCTLIGHT CEO, Thor Ansbæk, will be participating in the upcomming Laser World of Photonics exhibition from June 25 – 26 in Munich.

Give us a call or send an e-mail if you would like to schedule a meeting!

Phone: +45 53 86 27 | Mail: thor@octlight.com

Image is copyright of Messe München.

OCTLIGHT has been selected as being among the 50 most promising impact companies in the Nordics from 7000 screened startups.

CEO Thor Ersted Ansbæk comments:”We are honoured to have been selected between 1000 nordic startups and SME’s as in the top 50 of companies with an impact agenda. We are purpose driven with the mission to improve life quality, specifically eye health, by engaging with the healthcare community globally. According to WHO 285 million people worldwide are visually impaired and we work hard to enable early diagnosis necessary to prevent eye diseases from turning into blindness.”

We are really excited and humbled for the recognition for our work towards UN Sustainable Development Goals #sdgs #sustainabledevelopmentgoals

We thrive to improve quality of life worldwide together with our partners within the health community

After a very succesful Photonics West 2019, where OCTLIGHT exhibited in early February in order to engage with prospective customers, the OCTLIGHT production team has been hard at work to increase the through-put of VCSELs to ramp up our production.

From the Photonics West 2019 trade-show it was evident that VCSEL technology is seen to play a major role in upcoming OCT products for Ophthalmology with several announcements of advancement of 1060 nm wavelength tunable VCSEL technology.

Sample VCSEL wafers from the most recent wafer run.
Sample VCSEL wafers from the most recent production run. A 2″ VCSEL wafer contains more than 16,000 VCSELs which are binned after wafer-scale testing to meet specifications of the OCT Swept Source product.

The added effort put into the cleanroom semiconductor facilities has been fruitful, making the recent VCSEL wafer production run our most succesful yet.

The VCSELs will be put to use in Caliper OCT Swept Source modules for OEM sampling in 2019. VCSELs are also taken out for long-term reliability testing to document that OCTLIGHT VCSEL technology delivers the same reliability as well-established InGaAs VCSEL technology.

Take a look at our product page for more information about what our VCSELs are used for.

You can also call us on +45 53 86 27 37 for a discussion about how our technology might fit into your product roadmap.

Matter PR recently came by to create a story on OCTLIGHT and how we have grown and developed thanks to support from Actphast. The result is the following video where we showcase one of our prototypes and the laboratories we work in. CEO, Thor Ansbæk, was interviewed about the process and growing the company.

Read more about the story on Actphast’s website or in the articles made by Eyewire and BioOptics World

OCT Swept Source product Caliper targeting biometry in connection with cataract surgery

OCTLIGHT ApS announces that it will release its first product Caliper at the SPIE Photonics West 2019 Exhibition at the Moscone Center in San Francisco, US, February 5th. Caliper is an OCT swept source with application in 3D measurements of the eye geometry – so-called biometry – which finds its use in the treatment of cataract.

OEM samples will be available 2019 to meet demand for VCSEL based OCT Swept Source

The release of the Caliper product follows years of testing prototypes with potential customers within Ophthalmology. OCTLIGHT is currently ramping up its in-house VCSEL production to meet the anticipated volumes and scaling the organization accordingly.

There is currently a rapidly increasing interest in VCSELs for 3D imaging due to their mass manufacturability and unique properties of truly single-mode lasing, enabling fast and long coherence length wavelength sweep.

OCTLIGHT will make OEM samples available for customer testing and evaluation during 2019 in advance of planned production ramp-up and building its quality assurance system. The OEM samples will be available as stand-alone units and with turn-key benchtop enclosure.

Find the Press Release on Optics.org

For more information, meet us at Booth 5675 at the Photonics West 2019 Exhibition. Entry is free of charge!

Alternatively, contact CEO Thor Ansbaek: thor@octlight.com

OCTLIGHT ApS – Established in 2014. Headquarter in Kgs. Lyngby, Denmark. Development and sales of VCSEL enabled swept source technology for Optical Coherence Tomography.

We will be present at Photonics West 2019 February 5-7 in San Francisco, California, USA. We look forward to update current customers on our progress and meet new to discuss applications of our OCT Swept Source.

We will be showcasing at booth 5675. Locate us using the overview map.

Please fill out this contact form about your availability and we will return to you to schedule a meeting.

We will be present at The American Academy of Ophthalmology (AAO) Annual Meeting 2018 the 28-29th of October. Please contact us to hear more about the planned release of our OCT swept source for biometry and discuss your needs according to your product road map.

Finn Halken has been appointed Chairman of the Board of OCTLIGHT ApS. This further strengthens the commercial introduction of OCTLIGHT’s products to the Ophthalmology market.

As part of the Board of Directors, he brings key expertise in scaling manufacturing and global sales from his previous role as Group CEO/owner at Informationsteknik Scandinavia and CEO at Danish Interpretation Systems, which was acquired by Shure in 2011. Finn Halken will work closely together with CEO Thor Ansbæk in building  OCTLIGHT to meet the needs of system integrators in industries with high quality requirements, such as the ophthalmic device industry.

Finn Halken succeeds Bent Bischoff, who has had a pivotal role in the spin-out of OCTLIGHT’s core technology from The Technical University of Denmark. OCTLIGHT is grateful for his professional role in developing OCTLIGHT to its current state, with funding secured and OCT Swept Source ready for market introduction.

We will be present at The 36th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) the 22-23rd of September. Please contact us to hear more about the planned release of our OCT swept source for biometry and discuss your needs according to your product road map.